Jump to: Page Content, Site Navigation, Site Search,
You are seeing this message because your web browser does not support basic web standards. Find out more about why this message is appearing and what you can do to make your experience on this site better.
Published 13 May 2009, doi:10.1136/bmj.b1686
Cite this as: BMJ 2009;338:b1686
Moses J Bockarie, director, David H Molyneux, senior professorial fellow
1 Centre for Neglected Tropical Diseases, Liverpool School of Tropical Medicine, Liverpool L3 5QA
Correspondence to: M J Bockarie moses.bockarie@liv.ac.uk
Many programmes to improve health in poor countries are struggling to meet their targets, but as Moses Bockarie and David Molyneux report, elimination of lymphatic filariasis has a real chance of success
| The first 150 words of the full text of this article appear below. |
When the British physician Patrick Manson incriminated mosquitoes as vectors of Wuchereria bancrofti in China in 1877, it was the first time that an insect had been associated with the active transmission of an agent of any human or animal disease. The minute filarial worms (microfilariae), were, however, first observed as blood parasites by another British physician, Timothy Lewis. A BMJ report in 1870 records he had noticed microfilariae in the urine of patients.1 Manson had read Lewiss work and postulated that the worms lived in the lymphatic system, and that like other similar parasites, the females produced larvae viviparously. His curiosity about the fate of the microfilariae led to the discovery that they were transmitted by mosquitoes.
Lymphatic filariasis is a major cause of acute and chronic morbidity of humans in tropical and subtropical areas of Asia, Africa, the western Pacific, and some parts of the Americas. Over 20%
![]()
CiteULike
Complore
Connotea
Del.icio.us
Digg
Reddit
StumbleUpon
Technorati What's this?